Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

570 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical usefulness of an ultra-high-sensitivity hepatitis B surface antigen assay to determine the cessation of treatment for HBV reactivation.
Suzuki T, Tamori A, Matsuura K, Inoue T, Kusumoto S, Hagiwara S, Sagi H, Kaneko A, Murakami S, Kawamra H, Fujiwara K, Aoyagi K, Enomoto M, Kozuka R, Kataoka H, Tanaka Y. Suzuki T, et al. Among authors: kusumoto s. Ann Hepatol. 2024 Dec 3;30(1):101764. doi: 10.1016/j.aohep.2024.101764. Online ahead of print. Ann Hepatol. 2024. PMID: 39638038 Free article.
Clinical significance of NOTCH1 and FBXW7 alterations in adult T-cell leukemia/lymphoma.
Sakamoto Y, Ishida T, Masaki A, Murase T, Ohtsuka E, Takeshita M, Muto R, Choi I, Iwasaki H, Ito A, Kusumoto S, Nakano N, Tokunaga M, Yonekura K, Tashiro Y, Suehiro Y, Iida S, Utsunomiya A, Ueda R, Inagaki H. Sakamoto Y, et al. Among authors: kusumoto s. Int J Hematol. 2024 Nov 25. doi: 10.1007/s12185-024-03880-3. Online ahead of print. Int J Hematol. 2024. PMID: 39586983
Valemetostat for patients with relapsed or refractory peripheral T-cell lymphoma (VALENTINE-PTCL01): a multicentre, open-label, single-arm, phase 2 study.
Zinzani PL, Izutsu K, Mehta-Shah N, Barta SK, Ishitsuka K, Córdoba R, Kusumoto S, Bachy E, Cwynarski K, Gritti G, Prica A, Jacobsen E, Feldman T, Guillermin Y, Ennishi D, Yoon DH, Domenech ED, Zain J, Wang J, Kim JS, Poel MV, Jin J, Wu S, Chen Y, Moriyama T, Inoue A, Nakajima K, Horwitz SM. Zinzani PL, et al. Among authors: kusumoto s. Lancet Oncol. 2024 Dec;25(12):1602-1613. doi: 10.1016/S1470-2045(24)00503-5. Epub 2024 Oct 29. Lancet Oncol. 2024. PMID: 39486433 Clinical Trial.
Valemetostat monotherapy in patients with relapsed or refractory non-Hodgkin lymphoma: a first-in-human, multicentre, open-label, single-arm, phase 1 study.
Maruyama D, Jacobsen E, Porcu P, Allen P, Ishitsuka K, Kusumoto S, Narita T, Tobinai K, Foss F, Tsukasaki K, Feldman T, Imaizumi Y, Izutsu K, Morishima S, Yamauchi N, Yuda J, Brammer JE, Kawamata T, Ruan J, Nosaka K, Utsunomiya A, Wang J, Zain J, Kakurai Y, Yamauchi H, Hizukuri Y, Biserna N, Tachibana M, Inoue A, Horwitz SM. Maruyama D, et al. Among authors: kusumoto s. Lancet Oncol. 2024 Dec;25(12):1589-1601. doi: 10.1016/S1470-2045(24)00502-3. Epub 2024 Oct 29. Lancet Oncol. 2024. PMID: 39486432 Clinical Trial.
Baseline forced oscillation technique predicting lack of exacerbations in adult with asthma: A 12-month prospective.
Miyata Y, Tanaka A, Ebato T, Kashima A, Nojo M, Matsunaga T, Kaneko K, Okazaki T, Ohta S, Homma T, Watanabe Y, Kusumoto S, Suzuki S, Sagara H. Miyata Y, et al. Among authors: kusumoto s. Ann Allergy Asthma Immunol. 2024 Oct 4:S1081-1206(24)01553-9. doi: 10.1016/j.anai.2024.09.018. Online ahead of print. Ann Allergy Asthma Immunol. 2024. PMID: 39370038
570 results